Document Detail

A prospective, randomized, controlled study to compare two doses of recombinant human chorionic gonadotropin in serum and follicular fluid in woman with high body mass index.
MedLine Citation:
PMID:  19782346     Owner:  NLM     Status:  MEDLINE    
This prospective, randomized, controlled study compares the efficiency of 250 microg or 500 microg of recombinant hCG in serum and follicular fluid (FF) levels and pregnancy rates (PR) in women with high body mass index (BMI) (>or=26 kg/m(2)) undergoing assisted reproduction treatment (ART). Treatment outcomes are similar between the two groups.
Semra Kahraman; Guvenc Karlikaya; Mustecep Kavrut; Hale Karagozoglu
Related Documents :
16727506 - Sperm motion and rheological behavior of the vaginal fluid of superovulated dairy heifers.
17826536 - Nitric oxide: a new concept in chronic sinusitis pathogenesis.
19782346 - A prospective, randomized, controlled study to compare two doses of recombinant human c...
1123596 - Ballistic studies and lethal potential of tear gas pen guns firing fixed metallic ammun...
2344306 - Excessive physical work during pregnancy and birth weight.
12141876 - Seco-sethukarailin, a novel diterpenoid from the soft coral sinularia dissecta.
Publication Detail:
Type:  Comparative Study; Journal Article; Randomized Controlled Trial     Date:  2009-09-26
Journal Detail:
Title:  Fertility and sterility     Volume:  93     ISSN:  1556-5653     ISO Abbreviation:  Fertil. Steril.     Publication Date:  2010 Apr 
Date Detail:
Created Date:  2010-03-30     Completed Date:  2010-04-16     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0372772     Medline TA:  Fertil Steril     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2084-7     Citation Subset:  IM    
Copyright Information:
Copyright 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
Istanbul Memorial Hospital, Istanbul, Turkey.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Body Mass Index*
Chorionic Gonadotropin / administration & dosage*,  adverse effects,  analysis
Dose-Response Relationship, Drug
Follicular Fluid / chemistry,  drug effects*
Obesity / blood*,  metabolism
Oocyte Retrieval
Oocytes / drug effects,  metabolism
Overweight / blood*,  metabolism
Pregnancy Rate
Recombinant Proteins / administration & dosage,  adverse effects
Reproductive Techniques, Assisted
Treatment Outcome
Reg. No./Substance:
0/Chorionic Gonadotropin; 0/Recombinant Proteins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Reduced Orbitofrontal and Parietal Gray Matter in Chronic Insomnia: A Voxel-Based Morphometric Study...
Next Document:  Vitrification of isolated human blastomeres.